Identification of a gliadin T-cell epitope in coeliac disease: General importance of gliadin deamidation for intestinal T-cell recognition

Scandinavian Journal of Immunology

Volumn 48, Issue 2, 1998, Pages 111-115

  Sjostrom H ^a,b   Lundin, K E A ^b,c   Molberg, O ^b   Korner R ^d   Mcadam, S N ^b   Anthonsen, D ^a   Quarsten, H ^b   Noren O ^a   Roepstorff, P ^d   Thorsby, E ^b   Sollid, L M ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF OSLO   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLIADIN;

ARTICLE; CELIAC DISEASE; DEAMINATION; EPITOPE MAPPING; HUMAN; HUMAN CELL; INTESTINE CELL; INTESTINE MUCOSA; MASS SPECTROMETRY; MOLECULAR CLONING; MOLECULAR RECOGNITION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 2142764316     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1998.00397.x     Document Type: Article

References (28)

1. Trier JS. Celiac sprue. N Engl J Med 1991;325:1709-19.
2. Nepom GT, Erlich H. MHC class-II molecules and autoimmunity. Annu Rev Immunol 1991;9:493-525.
3. Thorsby E. Invited anniversary review: HLA associated diseases. Human Immunol 1997;53:1-11.
4. Sollid LM, Markussen G, Ek J, Gjerde H, Vartdal F, Thorsby E. Evidence for a primary association of celiac disease to a particular HLA-DQ α/β heterodimer. J Exp Med 1989;169:345-50.
5. Sollid LM, Thorsby E. HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterol 1993;105:910-22.
6. Lundin KEA, Scott H, Hansen T, Paulsen G, Halstensen TS, Fausa O, Thorsby E, Sollid LM. Gliadin-specific, HLA-DQ (α1*0501, 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med 1993;178:187-96.
7. Lundin KEA, Scott H, Fausa O, Thorsby E, Sollid LM. T cells from the small intestinal mucosa of a DR4, DQ7/DR4, DQ8 celiac disease patient preferentially recognise gliadin when presented by DQ8. Human Immunol 1994;41:285-91.
8. Molberg Ø, Kett K, Scott H, Thorsby E, Sollid LM, Lundin KEA. Gliadin specific, HLA DQ2-restricted T cells are commonly found in small intestinal biopsies from coeliac disease patients, but not from controls. Scand J Immunol 1997;46:103-8.
9. Lundin KEA, Sollid LM, Anthonsen D, Norén O, Molberg Ø, Thorsby E, Sjöström H. Heterogeneous reactivity patterns of HLA-DQ-restricted small intestinal T-cell clones from patients with celiac disease. Gastroenterol 1997;112:752-9.
10. Sjöström H, Friis SU, Norén O, Anthonsen D. Purification and characterisation of antigenic gliadins in coeliac disease. Clin Chim Acta 1992;207:227-37.
11. Stone KL, LoPresti MB, Crawford JM, DeAngelis R, Williams KR. Enzymatic digestion of proteins and HPLC peptide isolation. In: Matsudaira PT, ed. A practical guide to protein and peptide purification for microsequencing. San Diego: Academic Press, 1989:31-47.
12. Karas M, Hillenkamp F. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Anal Chem 1988;60:2299-301.
13. Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM. Electrospray ionization for mass spectrometry of large biomolecules. Science 1989;246:64-71.
14. Hunt DF, Yates JR, Shabanowitz J, Winston S, Hauer CR. Protein sequencing by tandem mass spectrometry. Proc Natl Acad Sci USA 1986;83:6233-7.
15. Cooks GL, Glish GL, McLuskey SA, Kaiser RE. Ion trap mass spectrometry. Chemical Engineering News 1991;25:26-41.
16. Thiede B, Wittmann-Liebold B, Bienert M, Krause E. MALDI-MS for C-terminal sequence determination of peptides and proteins degraded by carboxypeptidase Y and P. FEBS Lett 1995;357:65-9.
17. Johansen BH, Buus S, Vartdal F, Viken H, Eriksen JA, Thorsby E, Sollid LM. Binding of peptides to HLA-DQ molecules: peptide binding properties of the disease-associated HLA-DQ (α1*0501, β1*0201) molecule. Int Immunol 1994;6:453-61.
18. Frazer AC, Fletcher MB, Ross CAL, Shaw B, Sammons HG, Schneider R. Gluten-induced enteropathy: the effect of partially digested gluten. Lancet 1959;5:252-5.
19. Shewry PR, Tatham AS, Kasarda DD. Cereal proteins and coeliac disease. In: Marsh MN, ed. Coeliac disease. Oxford: Blackwell Scientific Publications, 1992:305-348.
20. Sugiyama T, Rafalski JA, Söll D. The nucleotide sequence of a wheat γ-gliadin genomic clone. Plant Sci 1986;44:205-9.
21. Johansen BH, Vartdal F, Eriksen JA, Thorsby E, Sollid LM. Identification of a putative motif for binding of peptides to HLA-DQ2. Int Immunol 1996;8:177-82.
22. van de Wal Y, Kooy YMC, Drijfhout JW, Amons R, Koning F. Peptide binding characteristics of the coeliac disease-associated DQ (α1*0501, β1*0201) molecule. Immunogenetics 1996;44:246-53.
23. Vartdal F, Johansen BH, Friede T, Thorpe CJ, Stevanović S. Eriksen JA, Sletten K, Thorsby E, Rammensee HG, Sollid LM. The peptide binding motif of the disease associated HLA-DQ (α1*0501, β1*0201) molecule. Eur J Immunol 1996;26:2764-72.
24. Koelle DM, Johnson ML, Ekstrom AN, Byers P, Kwok WW. Preferential presentation of herpes simplex virus T-cell antigen by HLA DQA1*0501/DQB1*0201 in comparison to HLA DQA1*0201/DQB1*0201. Human Immunol 1997;53:195-205.
25. Molberg Ø, McAdam SN, Kömer R, Quarsten H, Kristiansen C, Madsen L, Fugger L, Scott H, Norén O, Roepstorff P, Lundin KEA, Sjöström H, Sollid LM. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut derived T cells in celiac disease. Nature Med 1998;4:713-7.
26. Ogawa M, Kosaki G, Matsuura K, Fujimoto KI, Minamiura N, Yamamoto T, Kikuchi M. Modification of human pancreatic amylase isoenzymes by peptidoglutaminase I and II. Clin Chim Acta 1978;87:17-21.
27. Agunod M, Yamaguchi N, Lopez R, Luhby AL, Glass GB. Correlative study of hydrochloric acid, pepsin, and intrinsic factor secretion in newborns and infants. Am J Dig Dis 1969;14:400-14.
28. Rammensee HG, Friede T, Stevanović S. MHC ligands and peptide motifs: first listing. Immunogenetics 1995;41:178-228.